Abstract:PARP1 (ARTD1) and Tankyrases (TNKS1/TNKS2; PARP5a/5b) are poly-ADP-ribose polymerases (PARPs) with catalytic and non-catalytic functions that regulate both the genome and proteome during zygotic genome activation (ZGA), totipotent, and pluripotent embryonic stages. Here, we show that primed, conventional human pluripotent stem cells (hPSC) cultured continuously under non-specific TNKS1/TNKS2/PARP1-inhibited chemical naive reversion conditions underwent epigenetic reprogramming to clonal blastomere-like stem cells. TIRN stem cells concurrently expressed hundreds of gene targets of the ZGA-priming pioneer factor DUX4, as well as a panoply of four-cell (4C)-specific (e.g., TPRXL, HOX clusters), eight-cell (8C)-specific (e.g., DUXA, GSC, GATA6), primitive endoderm-specific (e.g., GATA4, SOX17), trophectoderm-specific (e.g., CDX2, TFAP2C), and naive epiblast-specific (e.g., DNMT3L, NANOG, POU5F1(OCT4)) factors; all in a hybrid, combinatorial single-cell manner. Mapping of proteomic and single-cell expressions of TIRN cells against human preimplantation embryo references identified them as relatively homogenous 4C-8C stage populations. Injection of TIRN cells into murine 8C-16C-staged embryos resulted in efficient totipotent-like single cell contributions of human cells to both extra-embryonic (trophectoderm, placenta) and embryonic (neural, fetal liver, hematopoietic) lineages in human-murine blastocyst and fetal chimeras. Pairing of proteome with ubiquitinome analyses of TIRN cells revealed a global shutdown of ADP-ribosylation, and a perturbed TNKS/PARP1 equilibrium which not only impacted the protein levels of hundreds of TNKS/PARP1 substrates via a rewiring of the ubiquitin-proteosome system (UPS), but also de-repressed expression of hundreds of developmental genes associated with PARP1 suppression. ChIP-Seq analysis of core NANOG-SOX2-OCT4 (NSO) pluripotency factors in TIRN cells identified reprogrammed DUX4-accessible distal and cis-regulatory enhancer regions that were co-bound by PARP1 (NSOP). These NSOP enhancer regions possessed co-binding motifs for hundreds of the same ZGA-associated, embryonic, and extraembryonic lineage-specifying pioneer factors (e.g., HOX, FOX, GATA, SOX, TBX, CDX families) that were concurrently co-expressed in TIRN cells; suggesting that PARP1 and DUX4 cooperate with NSO pluripotency core factors to regulate the epigenetic plasticity of a human totipotency program. These findings provide the first demonstration that global, proteome-wide perturbations of post-translational modifications (i.e., ADP-ribosylation, ubiquitination) can regulate epigenetic reprogramming during human embryogenesis. Totipotent TIRN stem cells will provide a valuable cell culture model for studying the proteogenomic regulation of lineage specification from human blastomere stages and may facilitate the efficient generation of human organs in interspecies chimeras.

What problem does this paper attempt to address?

This paper aims to solve the problem of how to reprogram human pluripotent stem cells (hPSC) to reach a functional totipotent stem cell state by regulating specific protein modification processes. Specifically, the research team focuses on treating conventional human pluripotent stem cells with the non - specific PARP inhibitor XAV939 by inhibiting the activities of PARP1 and Tankyrases (TNKS1/TNKS2), inducing these cells to undergo epigenetic reprogramming, and thus transform into totipotent stem cells (TIRN - SC) similar to the early embryonic development stage (4 - 8 - cell stage). This process involves extensive proteomic and ubiquitination modification changes, which not only affect the protein levels of hundreds of TNKS/PARP1 substrates, but also derepress the expression of hundreds of developmental genes related to PARP1 inhibition. The key to the research lies in revealing how PARP1 and DUX4 work together on core pluripotency factors (such as NANOG, SOX2 and OCT4) to regulate the epigenetic plasticity of the human totipotency program. Through this mechanism, the research team has successfully generated totipotent stem cells with high - efficiency differentiation ability. These cells can effectively contribute to embryonic and extra - embryonic tissues in human - mouse chimeras, showing their potential for generating human organs in cross - species chimeras. In general, this research has solved how to achieve the transformation from human pluripotent stem cells to totipotent stem cell states by regulating specific protein modification pathways, which provides an important theoretical basis and technical means for understanding the molecular mechanisms of early embryonic development and developing new regenerative medicine strategies.

Proteogenomic Reprogramming to a Functional Human Totipotent Stem Cell State via a PARP-DUX4 Regulatory Axis

Rolling back human pluripotent stem cells to an eight-cell embryo-like stage

Reprogramming roadmap reveals route to human induced trophoblast stem cells

Rolling back of human pluripotent stem cells to an 8-cell embryo-like stage

Translational and post-translational control of human naïve versus primed pluripotency

The TFAP2C-Regulated OCT4 Naive Enhancer is Involved in Human Germline Formation.

Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency

Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos

Epigenetic reprogramming in the transition from pluripotency to totipotency

Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency

A CRISPR/Cas9-based Kinome Screen Identifies ErbB Signaling As a New Regulator of Human Naïve Pluripotency and Totipotency

Reprogramming Primordial Germ Cells into Pluripotent Stem Cells

Robust Activation of the Human but Not Mouse Telomerase Gene During the Induction of Pluripotency

Molecular Mechanisms of Pluripotency and Reprogramming

Transcriptional Factors Mediated Reprogramming to Pluripotency

A PERTURBATION CELL ATLAS OF HUMAN INDUCED PLURIPOTENT STEM CELLS

In vitro reconstitution of epigenetic reprogramming in the human germ line

Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Widespread Tissue Contribution

Differential Transcriptomes and Methylomes of Trophoblast Stem Cells From Naturally-Fertilized and Somatic Cell Nuclear-Transferred Embryos

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

Capturing Transitional Pluripotency through Proline Metabolism